<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484767</url>
  </required_header>
  <id_info>
    <org_study_id>mRNA-3704-P001</org_study_id>
    <nct_id>NCT03484767</nct_id>
  </id_info>
  <brief_title>A Natural History Study to Characterize the Signs and Symptoms of Patients With Organic Acidemias</brief_title>
  <official_title>A Longitudinal, Exploratory, Natural History Study to Further Characterize and Describe the Signs and Symptoms of Patients With Organic Acidemias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moderna Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moderna Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Longitudinal, exploratory, natural history study of patients with MMA due to mut deficiency
      to characterize the changes in blood disease biomarkers over time and the frequency and
      severity of clinical events related to their disease.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma methylmalonic acid levels</measure>
    <time_frame>Baseline through 36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants (mut0 and mut- MMA patients) with disease-related clinical events as assessed by DAIDS 2017, corrected version 2.1</measure>
    <time_frame>Baseline through 36 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Methylmalonic Acidemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals aged 0-70 with confirmed diagnosis of isolated MMA due to MUT deficiency (mut0
        or mut-)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is 0 to 70 years old

          -  Patient has a confirmed diagnosis of isolated MMA due to MUT deficiency (mut0 or mut-)
             based on the following criteria:

               -  Elevated plasma/serum or urine methylmalonic acid levels

               -  Presence of normal serum/plasma vitamin B12 and plasma homocysteine levels

               -  Confirmed by molecular genetic testing or complementation analysis

          -  Patient (and/or legally authorized representative as applicable to local regulations)
             is willing and able to comply with study-related assessments and activities

          -  Patient or legally authorized representative is willing and able to provide informed
             consent and/or assent as mandated by local regulation

        Exclusion Criteria:

          -  Estimated GFR &lt;30 mL/min/1.73m2 based on age appropriate equations or patients who
             undergo chronic dialysis

          -  Patients diagnosed with isolated MMA cblA, cblB, or cblD enzymatic subtypes or
             methylmalonyl-CoA epimerase deficiency or combined MMA with homocystinuria

          -  The patient is pregnant or lactating at the time of screening. (Note: Patients who
             become pregnant during the study may remain in the study)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Moderna Clinical Trials</last_name>
    <phone>855-663-6762</phone>
    <email>clinicaltrials@modernatx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>methylmalonic acidemia</keyword>
  <keyword>MMA</keyword>
  <keyword>organic acidemia</keyword>
  <keyword>mut deficiency</keyword>
  <keyword>inborn errors of metabolism</keyword>
  <keyword>mut0</keyword>
  <keyword>mut-</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Signs and Symptoms</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Amino Acid Metabolism, Inborn Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

